• Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement

    Monday October 23rd 2023

  • Agomab raises $100 million Series C to advance fibrosis-focused pipeline

    Wednesday October 11th 2023

  • Agreement regarding recapitalization of operating subsidiaries by secured creditors and wind down of listed holding company

    Tuesday September 26th 2023

  • SimAbs secures €1 million investment for advanced antibody production

    Monday September 25th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023

  • AbolerIS Pharma announces €27 million in Series A financing to advance its novel treatment paradigm for autoimmune and inflammatory diseases

    Sunday September 17th 2023

  • ENOUGH raises €40M growth funding co-led by World Fund and CPT to scale up production

    Monday August 21st 2023

  • Your news here?

  • Mithra receives EUR 1.25 million milestone payment from Fuji Pharma under Estelle® licensing agreement

    Thursday August 3rd 2023

  • argenx raises $1.1 billion in gross proceeds in a global offering

    Wednesday July 19th 2023

  • VUB neurologist argues for affordability of new Alzheimer’s drug

    Friday July 14th 2023

Strategic Partners